振东制药(300158)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300158 振东制药

已收盘 10-10 15:00:00

{"stockData":{"symbol":"300158","market":"SZ","secType":"STK","nameCN":"振东制药","latestPrice":6.84,"timestamp":1760079819000,"preClose":6.61,"halted":0,"volume":69422474,"delay":0,"changeRate":0.0348,"floatShares":1005000000,"shares":1005000000,"eps":-1.3442,"marketStatus":"已收盘","change":0.23,"latestTime":"10-10 15:00:00","open":6.61,"high":6.98,"low":6.6,"amount":473000000,"amplitude":0.0575,"askPrice":6.85,"askSize":1520,"bidPrice":6.84,"bidSize":1245,"shortable":0,"etf":0,"ttmEps":-1.3442,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1760319000000},"marketStatusCode":5,"adr":0,"adjPreClose":6.61,"symbolType":"stock","openAndCloseTimeList":[[1760059800000,1760067000000],[1760072400000,1760079600000]],"highLimit":7.27,"lowLimit":5.95,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1005319756,"isCdr":false,"pbRate":1.82,"roa":"--","roe":"0.21%","epsLYR":-1.2977,"committee":0.054093,"marketValue":6876000000,"turnoverRate":0.0691,"status":0,"floatMarketCap":6872000000},"requestUrl":"/m/hq/s/300158","defaultTab":"news","newsList":[{"id":"2574127140","title":"振东制药为全资子公司安欣制药提供5000万元担保","url":"https://stock-news.laohu8.com/highlight/detail?id=2574127140","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574127140?lang=zh_cn&edition=full","pubTime":"2025-10-10 18:20","pubTimestamp":1760091658,"startTime":"0","endTime":"0","summary":"中访网数据  山西振东制药股份有限公司于2025年10月10日召开第六届董事会第六次会议，审议通过了《关于为全资子公司提供担保的议案》。为满足全资子公司山西振东安欣生物制药有限公司的经营发展需求，董事会同意安欣制药向银行申请总额不超过人民币5000万元的综合授信额度。同时，公司将为该笔授信提供总额不超过5000万元的担保，担保形式包括信用担保、抵押担保、质押担保或其组合等多种方式，具体担保期限将以最终与银行签署的协议为准。此次担保旨在支持子公司的业务拓展和资金周转，符合公司整体发展战略。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251010/31697026.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0060","BK0186","BK1191","01477","BK0239","BK1574","300158"],"gpt_icon":0},{"id":"2574132059","title":"振东制药控股股东振东集团办理股份解押及质押","url":"https://stock-news.laohu8.com/highlight/detail?id=2574132059","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574132059?lang=zh_cn&edition=full","pubTime":"2025-10-09 17:09","pubTimestamp":1760000995,"startTime":"0","endTime":"0","summary":"中访网数据 山西振东制药股份有限公司近日发布公告，其控股股东山西振东健康产业集团有限公司办理了部分股份的解押及质押业务。截至公告日，振东集团及其一致行动人合计持有公司30.29%的股份，其中处于质押状态的股份数量为1.48亿股，占其合计持股的48.70%，占公司总股本的14.75%。公司表示，振东集团具备资金偿还能力，本次股份质押事项不会对公司的生产经营和公司治理产生实质性影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251009/31692815.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0186","BK0060","300158","BK0239"],"gpt_icon":0},{"id":"2571340775","title":"振东制药：4亿元支付给北京朗迪制药有限公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2571340775","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571340775?lang=zh_cn&edition=full","pubTime":"2025-09-30 20:51","pubTimestamp":1759236715,"startTime":"0","endTime":"0","summary":"证券之星消息，振东制药09月29日在投资者关系平台上答复投资者关心的问题。这1亿在7月份已支付，9月份成立公司！根据仲裁裁决，公司需支付总计人民币5亿元。其中，4亿元向北京朗迪制药有限公司支付，1亿元增资其全资子公司上海方朗实业有限公司。公司目前未开展“朗迪钙”产品的代工业务。根据公开信息，上海方朗实业有限公司成立于2022年7月26日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025093000037938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300158","BK0239","BK1191","01477","BK0186","BK1574","BK0060"],"gpt_icon":0},{"id":"2570865128","title":"振东制药：支付上海方朗实业1亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2570865128","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570865128?lang=zh_cn&edition=full","pubTime":"2025-09-26 20:52","pubTimestamp":1758891167,"startTime":"0","endTime":"0","summary":"证券之星消息，振东制药09月26日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好：最近在网上查询到公司参股上海方朗实业有限公司的近20%的股权！这家公司另一家是北京朗迪制药有限公司占比80%股权！根据仲裁结果，公司向朗迪公司子公司上海方朗实业有限公司支付了人民币1亿元。具体情况详见公司于2025年1月24日发布在巨潮资讯网上的《关于公司重大仲裁事项进展的公告》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092600036475.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","BK0060","300158","BK0239"],"gpt_icon":0},{"id":"2569782770","title":"振东制药：国际中医药治疗肿瘤联盟推进中药国际化","url":"https://stock-news.laohu8.com/highlight/detail?id=2569782770","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569782770?lang=zh_cn&edition=full","pubTime":"2025-09-22 20:51","pubTimestamp":1758545482,"startTime":"0","endTime":"0","summary":"证券之星消息，振东制药(300158)09月22日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，您好，去年十一月，国际中医药治疗肿瘤联盟正式成立，贵公司作为唯一一家国内参与单位，对于提高公司国内国际知名度有积极意义和影响，是否会进一步打开国内国际市场？提高公司产品在国际的份额振东制药回复：尊敬的投资者您好！2014年11月，公司联合中国中医科学院在美国成立涵盖22个国家的“国际中医药治疗肿瘤联盟”，该事项对公司推进中药国际化有积极影响。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092200032310.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300158","BK0186","BK0239","BK0060"],"gpt_icon":0},{"id":"2569782088","title":"振东制药：股东可发持股证明查人数","url":"https://stock-news.laohu8.com/highlight/detail?id=2569782088","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569782088?lang=zh_cn&edition=full","pubTime":"2025-09-22 20:51","pubTimestamp":1758545482,"startTime":"0","endTime":"0","summary":"证券之星消息，振东制药(300158)09月22日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，董秘，投资者想要知道股东人数需要提供股东账户卡，我们买了公司股票，也没有股东卡啊！能在说的具体一点吗？如何获得或者提供股东账户卡？振东制药回复：尊敬的投资者您好！您可将持股证明、身份证明发送至公司邮箱（zqb@zdjt.com），公司核实您的股东身份后，将在3个工作日内通过邮件或电话（0355-8096012）的方式回复您最新的股东人数。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092200032311.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","BK0060","300158","BK0239"],"gpt_icon":0},{"id":"2568477234","title":"振东制药：创新药乳杆菌二联活菌胶囊Pre-NDA申请获CDE受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2568477234","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568477234?lang=zh_cn&edition=full","pubTime":"2025-09-18 20:51","pubTimestamp":1758199910,"startTime":"0","endTime":"0","summary":"证券之星消息，振东制药(300158)09月17日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，公司创新药乳杆菌二联活菌胶囊在官网查询已经亮灯，是否代表本月可以拿到生产批件？振东制药回复：尊敬的投资者您好！公司创新药乳杆菌二联活菌胶囊Pre-NDA申请已获CDE受理。后续尚需完成提交新药上市申请，经过审评、现场核查等严格的审批审评程序方可上市销售。公司将根据后续进展情况及时履行信息披露义务，敬请广大投资者谨慎决策，注意防范投资风险。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091800035385.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","300158","BK1574","06978","BK0186","BK0239","159992","BK1161"],"gpt_icon":0},{"id":"2567114971","title":"振东制药：安喹利司片正在进行Ⅰ期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2567114971","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567114971?lang=zh_cn&edition=full","pubTime":"2025-09-15 20:51","pubTimestamp":1757940677,"startTime":"0","endTime":"0","summary":"证券之星消息，振东制药(300158)09月15日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好：9月11号在临床试验官网上查询到贵公司的创新一类药：安喹利司片已经进入2期临床试验！请教是否属实！？公司可以发一个公告，让投资者增强对公司投资前景！谢谢！振东制药回复：尊敬的投资者您好！公司安喹利司片目前正在进行Ⅰ期临床试验中。后续达到信息披露标准时，公司将按照法律法规及相关规定，及时、准确地履行信息披露义务。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091500030764.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300158","BK0186","BK0060"],"gpt_icon":0},{"id":"2566469689","title":"振东制药（300158）股东山西振东健康产业集团有限公司质押1250万股，占总股本1.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566469689","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566469689?lang=zh_cn&edition=full","pubTime":"2025-09-09 18:23","pubTimestamp":1757413405,"startTime":"0","endTime":"0","summary":"证券之星消息，振东制药9月9日公开信息显示，股东山西振东健康产业集团有限公司向晋商银行股份有限公司长治分行合计质押1250.0万股，占总股本1.24%。质押详情见下表：截止本公告日，股东山西振东健康产业集团有限公司已累计质押股份1.56亿股，占其持股总数的51.5%。振东制药主营业务：肿瘤、毛发、消化、泌尿、心脑等仿制药、创新药的研发、生产、销售,以及种子种苗抚育、种植、加工、仓储、饮片于一体的中药材全产业链。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090900031574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","300158","BK0186"],"gpt_icon":0},{"id":"2564939687","title":"振东制药：公司不存在人为压制股价行为","url":"https://stock-news.laohu8.com/highlight/detail?id=2564939687","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564939687?lang=zh_cn&edition=full","pubTime":"2025-09-03 20:52","pubTimestamp":1756903943,"startTime":"0","endTime":"0","summary":"证券之星消息，振东制药09月03日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，公司调整回购上限至11元，回购期间会不会故意采取压低股价方式回购，贵司后期会不会布局科技产业振东制药回复：尊敬的投资者您好！公司严格遵循法律法规，不存在人为压制股价的行为。未来如有涉及公司业务方向的重大变化或新领域拓展计划，公司将严格按照相关法律法规及时履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090300036405.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","BK0060","BK0239","300158"],"gpt_icon":0},{"id":"2562834337","title":"农业种植概念26日主力净流出9363.48万元，振东制药、粤桂股份居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2562834337","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562834337?lang=zh_cn&edition=full","pubTime":"2025-08-26 15:54","pubTimestamp":1756194883,"startTime":"0","endTime":"0","summary":"8月26日，农业种植概念上涨0.9%，今日主力资金流出9363.48万元，概念股60只上涨，24只下跌。主力资金净流出居前的分别为振东制药、粤桂股份、宏辉果蔬、福达股份、北大荒。序号代码名称最新价涨跌幅主力净流入主力净占比1600704物产中大6.3410.071.61亿元7.17%2600737中粮糖业16.674.711.51亿元8.15%3000568泸州老窖140.831.321.44亿元5.79%4301556托普云农128.09.725829.40万元15.59%5300586美联新材13.082.273698.68万元5.71%6002326永太科技15.590.782632.32万元4.39%7300543朗科智能12.742.02327.42万元8.47%8002312川发龙蟒11.741.211981.77万元2.5%9000850华茂股份4.931.651972.64万元13.58%10002539云图控股11.5310.021831.88万元2.74%","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/26155452697311.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["000833","BK0081","BK0239","300158","BK0028","BK0265","BK0186","BK0060","BK0012"],"gpt_icon":1},{"id":"2562730772","title":"振东制药（300158）2025年中报简析：净利润同比下降74.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562730772","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562730772?lang=zh_cn&edition=full","pubTime":"2025-08-26 06:03","pubTimestamp":1756159393,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期振东制药发布2025年中报。根据财报显示，振东制药净利润同比下降74.13%。截至本报告期末，公司营业总收入14.57亿元，同比下降3.3%，归母净利润793.13万元，同比下降74.13%。按单季度数据看，第二季度营业总收入7.02亿元，同比下降3.05%，第二季度归母净利润677.41万元，同比下降10.35%。筹资活动产生的现金流量净额变动幅度为51.11%,原因:偿还借款及回购股份资金减少。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082600008140.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300158"],"gpt_icon":0},{"id":"2561250479","title":"振东制药：上半年净利793.13万元 同比下降74.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561250479","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561250479?lang=zh_cn&edition=full","pubTime":"2025-08-24 17:51","pubTimestamp":1756029081,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0186","BK0239","300158","BK0060"],"gpt_icon":0},{"id":"2561890250","title":"振东制药(300158)6月30日股东户数4.61万户，较上期减少5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561890250","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561890250?lang=zh_cn&edition=full","pubTime":"2025-08-24 17:01","pubTimestamp":1756026099,"startTime":"0","endTime":"0","summary":"证券之星消息，近日振东制药披露，截至2025年6月30日公司股东户数为4.61万户，较3月31日减少2449.0户，减幅为5.04%。在中药行业个股中，振东制药股东户数低于行业平均水平，截至6月30日，中药行业平均股东户数为5.45万户。从股价来看，2025年3月31日至2025年6月30日，振东制药区间涨幅为10.28%，在此期间股东户数减少2449.0户，减幅为5.04%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082400007700.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","300158","BK0239","BK0060"],"gpt_icon":0},{"id":"2558266653","title":"8月11日振东制药（300158）龙虎榜数据：游资瑞鹤仙上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2558266653","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558266653?lang=zh_cn&edition=full","pubTime":"2025-08-11 17:20","pubTimestamp":1754904019,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年8月11日公布的交易公开信息显示，振东制药因日涨幅达到15%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年8月11日收盘，振东制药报收于8.7元，上涨20.0%，涨停，换手率18.11%，成交量181.51万手，成交额14.58亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入740.48万元，北向资金合计净买入565.96万元。瑞鹤仙等知名游资榜上有名。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081100028165.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300158","BK0060","BK0186"],"gpt_icon":0},{"id":"2558634631","title":"异动快报：振东制药（300158）8月11日14点2分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2558634631","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558634631?lang=zh_cn&edition=full","pubTime":"2025-08-11 14:05","pubTimestamp":1754892332,"startTime":"0","endTime":"0","summary":"证券之星8月11日盘中消息，14点2分振东制药触及涨停板。目前价格8.7，上涨20.0%。其所属行业中药目前上涨。该股为肝炎概念，创新药，幽门螺杆菌概念概念热股，当日肝炎概念概念上涨2.54%，创新药概念上涨1.79%，幽门螺杆菌概念概念上涨1.74%。8月11日的资金流向数据方面，主力资金净流入1913.01万元，占总成交额2.19%，游资资金净流入1378.4万元，占总成交额1.58%，散户资金净流出3291.4万元，占总成交额3.77%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081100018064.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","BK0060","300158","BK0239"],"gpt_icon":0},{"id":"2558863139","title":"肝炎概念盘中拉升，振东制药涨14.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558863139","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558863139?lang=zh_cn&edition=full","pubTime":"2025-08-11 13:49","pubTimestamp":1754891393,"startTime":"0","endTime":"0","summary":"08月11日，肝炎概念盘中拉升，截至13点49分，肝炎概念整体指数上涨2.01%，报1185.250点。从个股上来看，该概念的成分股中，振东制药涨14.48%，安科生物涨幅超过10%，广生堂、美诺华等6只股涨幅超过5%。从资金上来看，截止发稿，肝炎概念概念主力净流入为-1.13亿，其中润都股份受到资金热捧，主力净流入5062.93万；拉长时间线来看，该板块近20日主力资金净流入-83.31亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081113495397403d11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081113495397403d11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["300158","BK0186","BK0060","603538","BK0239"],"gpt_icon":0},{"id":"2558639559","title":"幽门螺杆菌概念盘中拉升，振东制药涨9.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558639559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558639559?lang=zh_cn&edition=full","pubTime":"2025-08-11 13:12","pubTimestamp":1754889175,"startTime":"0","endTime":"0","summary":"08月11日，幽门螺杆菌概念盘中拉升，截至13点12分，幽门螺杆菌概念整体指数上涨1.02%，报1193.770点。从个股上来看，该概念的成分股中，振东制药涨9.24%，悦康药业、亚太药业等3只股涨幅超过5%。从资金上来看，截止发稿，幽门螺杆菌概念概念主力净流入为-5568.76万，其中亚太药业受到资金热捧，主力净流入7010.62万；拉长时间线来看，该板块近20日主力资金净流入-72.54亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081113125597402fbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081113125597402fbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0060","300158","688658","BK0186","BK0239"],"gpt_icon":0},{"id":"2557128344","title":"振东制药：继续收购优质产品引进临床在研品种","url":"https://stock-news.laohu8.com/highlight/detail?id=2557128344","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557128344?lang=zh_cn&edition=full","pubTime":"2025-08-06 11:48","pubTimestamp":1754452085,"startTime":"0","endTime":"0","summary":"证券之星消息，振东制药08月05日在投资者关系平台上答复投资者关心的问题。2024年报披露今年是破局年，收购更多的企业成熟药品，丰富产品管线！公司在战略并购方面，以“买产品、买技术、收企业”为指引，继续收购优质产品；同时，围绕公司战略领域，引进处于Ⅱ、Ⅲ期临床阶段的在研品种。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080600016542.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","BK0239","300158","BK0060"],"gpt_icon":0},{"id":"2556874683","title":"驱蚊概念股盘中跳水，振东制药跌7.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556874683","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556874683?lang=zh_cn&edition=full","pubTime":"2025-08-04 09:53","pubTimestamp":1754272399,"startTime":"0","endTime":"0","summary":"08月04日，驱蚊概念股盘中跳水，截至09点53分，驱蚊概念股整体指数下跌1.03%，报989.950点。从个股上来看，该概念的成分股中，振东制药跌7.36%，康芝药业、拉芳家化、万孚生物跌幅居前。从资金上来看，截止发稿，驱蚊概念股概念主力净流入为365.36万，其中彩虹集团受到资金热捧，主力净流入7668.74万；拉长时间线来看，该板块近20日主力资金净流入-6.50亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804095319a6d13c11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804095319a6d13c11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0229","603630","300158","BK0239","BK0186","BK0060"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1760136372284,"stockEarnings":[{"period":"1week","weight":0.0427},{"period":"1month","weight":-0.1128},{"period":"3month","weight":0.4553},{"period":"6month","weight":0.7766},{"period":"1year","weight":0.5336},{"period":"ytd","weight":0.5833}],"compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":0.0222},{"period":"3month","weight":0.1102},{"period":"6month","weight":0.2034},{"period":"1year","weight":0.1802},{"period":"ytd","weight":0.1627}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山西振东制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"46135人(较上一季度减少5.04%)","perCapita":"21777股","listingDate":"2011-01-07","address":"山西省长治市上党区光明南路振东科技园","registeredCapital":"100531万元","survey":"　　山西振东制药股份有限公司的主营业务是肿瘤、皮科、消化、泌尿、心脑等仿制药、创新药的研发、生产、销售，以及种子种苗抚育、种植、加工、仓储、饮片于一体的中药材全产业链。公司的主要产品是复方苦参注射液、米诺地尔搽剂、生白颗粒、舒血宁注射液、西黄丸、独一味颗粒、复方胰酶散、大山楂丸。公司荣获“全国先进基层党组织”“全国脱贫攻坚先进集体”两个荣誉称号，荣获“第七届百姓安全用药”放心药奖、“山西省著名商标”等荣誉。","listedPrice":38.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"振东制药(300158)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供振东制药(300158)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"振东制药,300158,振东制药股票,振东制药股票老虎,振东制药股票老虎国际,振东制药行情,振东制药股票行情,振东制药股价,振东制药股市,振东制药股票价格,振东制药股票交易,振东制药股票购买,振东制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"振东制药(300158)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供振东制药(300158)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}